Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Fujian Hengjie Bioloical Technology Co. Ltd. currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active case is assigned to 1 distinct examiner, which streamlines the communication between the applicant and the patent office. The application is being reviewed within 1 distinct art unit, providing a focused technical environment for the prosecution. This concentration allows for a specialized approach to the specific requirements of the 1 distinct art unit involved.
RAO, MANJUNATH N is identified as the busiest examiner for the portfolio, with 1 busiest examiner pending office action. Because the total count of 1 pending office action covers the entire active docket, this examiner is the sole official responsible for the company's applications. The alignment of 1 distinct examiner with the assigned technical group simplifies the management of the portfolio. Practitioners can focus on the specific examination style of this individual examiner to effectively navigate the pending office action toward a resolution and ensure all technical objections are addressed.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAO, MANJUNATH N | 1 | 11.3% | +23.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17790192 | METHOD FOR PREPARING NON-DENATURED TYPE II COLLAGEN | RAO, MANJUNATH N | 161d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17790192 | METHOD FOR PREPARING NON-DENATURED TYPE II COLLAGEN | RAO, MANJUNATH N | 161d overdue |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17790192 | METHOD FOR PREPARING NON-DENATURED TYPE II COLLAGEN | RAO, MANJUNATH N | 1656 | §103 | Non-Final OA | 161d overdue | Pending | Jun 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial